Objective: This study investigated whether liquid-based cytology (LBC) can improve diagnostic values of cytological assessment of endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA). Study Design: A cohort of 600 cases in West China Hospital was prospectively studied from June 2012 to September 2013. EBUS-TBNA was carried out in outpatients under local anesthesia and moderate sedation. The procedure was performed with an echobronchoscope (BF-UC160F-OL8, Olympus, Tokyo, Japan). Histological cores were stained with hematoxylin and eosin for further study. Additional immunohistological analysis was performed for establishing a reliable diagnosis when necessary. Aspirates were smeared on glass slides and separate aspirates were processed by the monolayer SurePath method. Results: In total, 480 malignant tumors and 120 benign lesions were confirmed by histological examination. The sensitivity of SurePath liquid-based preparations and conventional smears was 82.1 and 56%, and the specificity was 87.5 and 82.5%, respectively. The combined specificity was 100%. Positive predictive values of the two groups were 96.3 and 92.8%, whereas negative predictive values were 54.9 and 31.9%, respectively. The difference between the two groups was significant (p < 0.001). Conclusions: LBC preparation can improve cytological assessment of EBUS-TBNA. Histological study is necessary in cases in which the cytological diagnosis is obscure.

Keywords:
Endobronchial ultrasound-guided transbronchial needle aspiration, Liquid-based cytology, SurePath liquid-based preparation, Conventional smear
1.
Yasufuku K, Chiyo M, Sekine Y, Chhajed PN, Shibuya K, Iizasa T, et al: Real-time endobronchial ultrasound-guided transbronchial needle aspiration of mediastinal and hilar lymph nodes. Chest 2004;126:122-128.
2.
Ye T, Hu H, Luo X, Chen H: The role of endobronchial ultrasound guided transbronchial needle aspiration (EBUS-TBNA) for qualitative diagnosis of mediastinal and hilar lymphadenopathy: a prospective analysis. BMC Cancer 2011;11:100.
3.
Gu P, Zhao YZ, Jiang LY, Zhang W, Xin Y, Han BH: Endobronchial ultrasound-guided transbronchial needle aspiration for staging of lung cancer: a systematic review and meta-analysis. Eur J Cancer 2009;45:1389-1396.
4.
Adams K, Shah PL, Edmonds L, Lim E: Test performance of endobronchial ultrasound and transbronchial needle aspiration biopsy for mediastinal staging in patients with lung cancer: systematic review and meta-analysis. Thorax 2009;64:757-762.
5.
Navani N, Lawrence DR, Kolvekar S, Hayward M, McAsey D, Kocjan G, et al: Endobronchial ultrasound-guided transbronchial needle aspiration prevents mediastinoscopies in the diagnosis of isolated mediastinal lymphadenopathy: a prospective trial. Am J Respir Crit Care Med 2012;186:255-260.
6.
Steinfort DP, Liew D, Conron M, Hutchinson AF, Irving LB: Cost-benefit of minimally invasive staging of non-small cell lung cancer: a decision tree sensitivity analysis. J Thorac Oncol 2010;5:1564-1570.
7.
Schmid-Bindert G, Wang Y, Jiang H, Sun H, Henzler T, Wang H, et al: EBUS-TBNA provides highest RNA yield for multiple biomarker testing from routinely obtained small biopsies in non-small cell lung cancer patients - a comparative study of three different minimal invasive sampling methods. PLoS One 2013;8:e77948.
8.
Navani N, Brown JM, Nankivell M, Woolhouse I, Harrison RN, Jeebun V, et al: Suitability of endobronchial ultrasound-guided transbronchial needle aspiration specimens for subtyping and genotyping of non-small cell lung cancer: a multicenter study of 774 patients. Am J Respir Crit Care Med 2012;185:1316-1322.
9.
Sakairi Y, Hoshino H, Fujiwara T, Nakajima T, Yasufuku K, Yoshida S, et al: Validation of EBUS-TBNA-integrated nodal staging in potentially node-positive non-small cell lung cancer. Gen Thorac Cardiovasc Surg 2013;61:522-527.
10.
Asano F, Aoe M, Ohsaki Y, Okada Y, Sasada S, Sato S, et al: Complications associated with endobronchial ultrasound-guided transbronchial needle aspiration: a nationwide survey by the Japan Society for Respiratory Endoscopy. Respir Res 2013;14:50.
11.
Norimatsu Y, Kouda H, Kobayashi TK, Moriva T, Yanoh K,Tsukayama C, et al: Utility of thin-layer preparations in the endometrial cytology: evaluation of benign endometrial lesions. Ann Diagn Pathol 2008;12:103-111.
12.
Hattori M, Kobayashi TK, Nishimura Y, Machida D, Toyonaga M, Tsunoda S, et al: Comparative image analysis of conventional and thin-layer preparations in endometrial cytology. Diagn Cytopathol 2013;41:527-532.
13.
Norimatsu Y, Kouda H, Kobayashi TK, Shimizu K, Yanoh K, Tsukayama C, et al: Utility of liquid-based cytology in endometrial pathology: diagnosis of endometrial carcinoma. Cytopathology 2009;20:395-402.
14.
Takei H, Ruiz B, Hicks J: Cervicovaginal flora: comparison of conventional pap smears and a liquid-based thin-layer preparation. Am J Clin Pathol 2006;125:855-859.
15.
Norimatsu Y, Yanoh K, Kobayashi TK: The role of liquid-based preparation in the evaluation of endometrial cytology. Acta Cytol 2013;57:423-435.
16.
Beccati MD, Buriani C, Pedriali M, Rossi S, Nenci I: Quantitative detection of molecular markers ProEx C (minichromosome maintenance protein 2 and topoisomerase IIa) and MIB-1 in liquid-based cervical squamous cell cytology. Cancer 2008;114:196-203.
17.
Natu S, Hoffman J, Siddiqui M, Hobday C, Shrimankar J, Harrison R: The role of endobronchial ultrasound guided transbronchial needle aspiration cytology in the investigation of mediastinal lymphadenopathy and masses, the North Tees experience. J Clin Pathol 2010;63:445-451.
18.
Delattre C, Fournier C, Bouchindhomme B, Renaud F, Escande F, Ramon P, et al: Endoscopic ultrasound guided transbronchial fine needle aspiration: a French Department of Pathology's 4-year experience. J Clin Pathol 2011;64:1117-1122.
© 2015 S. Karger AG, Basel
2015
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.